Novavax COVID-19 vaccine shown highly effective in trial | The Hill: Healthcare Policy

Novavax on Monday revealed the results of its phase three COVID-19 vaccine trial, which determined that the company’s two-dose inoculation is highly effective.Clinical trials, which enrolled 29,960 participants across 119 states in the U.S. and...